Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9286888 | Virology | 2005 | 8 Pages |
Abstract
Mutagenic treatments resulted in occasional, not systematic, human immunodeficiency virus type 1 (HIV-1) extinction. To study the possibility that a combination of an antiretroviral inhibitor, to reduce the viral replicative load, and a mutagenic agent could be more effective in producing viral extinction than a mutagenic agent alone, we have compared the efficiency of extinction of HIV-1 by the mutagenic deoxyribonucleoside analogue 5-hydroxydeoxycytidine (5-OHdC) alone and in combination with the HIV-1 nucleoside reverse transcriptase (RT) inhibitor AZT. Serial passages in peripheral mononuclear cells (PBMC) or MT-4 cells of primary HIV-1 isolates or HIV-1 NL4-3 in the presence of a single drug (AZT 0.01μM or 5-OHdC 2 mM) failed to systematically extinguish high fitness HIV-1 replication after 16 serial transfers. However, systematic extinction of HIV-1 was observed when a combination of the mutagenic agent 5-OHdC and AZT was used. These results demonstrate that combinations of mutagenic agents and antiretroviral inhibitors have the potential to drive HIV-1 into extinction.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Natalia Tapia, Guerau Fernà ndez, Mariona Parera, Gemma Gómez-Mariano, Bonaventura Clotet, Miguel Quiñones-Mateu, Esteban Domingo, Miguel Angel MartÃnez,